Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 1
1989 1
1993 1
1994 8
1995 3
1997 9
1998 10
1999 3
2004 1
2005 1
2006 7
2007 4
2008 2
2010 5
2011 4
2012 6
2013 3
2014 5
2015 6
2016 6
2017 3
2018 4
2019 6
2020 6
2021 5
2022 7
2023 2
2024 7
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study.
Bonifati C, Lembo S, Richetta AG, Romanelli M, Satolli F, Corazza M, Atzori L, Lasagni C, Potenza C, Savoia P, Bardazzi F, Di Lernia VG, Bianchi L, Fabbrocini G, Giofrè C, Zichichi L, Guarneri C, Pallotta S, Fargnoli MC, Loconsole F, Offidani A, Burlando M, Piaserico S, Peris K, Papini M, Carrera CG, Costanzo A, Prignano F, Bongiorno MR, Dapavo P, Stingeni L, Donini M, Micali G, Rongioletti F, Stinco G, Gramiccia T, Cantini G, Argenziano G. Bonifati C, et al. J Eur Acad Dermatol Venereol. 2025 Mar;39 Suppl 1:7-14. doi: 10.1111/jdv.20187. Epub 2024 Jun 26. J Eur Acad Dermatol Venereol. 2025. PMID: 38924150
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study.
Mortato E, Talamonti M, Marcelli L, Megna M, Raimondo A, Caldarola G, Bernardini N, Balato A, Campanati A, Esposito M, Bonifati C, Lora V, Potestio L, Lembo S, Loconsole F, De Luca E, Skroza N, Buononato D, Bianchelli T, Fargnoli MC, Tommasino N, Primavera F, De Simone C, Bianchi L, Galluzzo M. Mortato E, et al. Among authors: bonifati c. Dermatol Ther (Heidelb). 2025 May;15(5):1239-1250. doi: 10.1007/s13555-025-01394-2. Epub 2025 Apr 16. Dermatol Ther (Heidelb). 2025. PMID: 40238056 Free PMC article.
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: the EARLY study.
Mortato E, Talamonti M, Marcelli L, Megna M, Raimondo A, Caldarola G, Bernardini N, Balato A, Campanati A, Esposito M, Bonifati C, Lora V, Potestio L, Lembo S, Loconsole F, De Luca E, Skroza N, Buononato D, Bianchelli T, Fargnoli MC, Tommasino N, Primavera F, De Simone C, Bianchi L, Galluzzo M. Mortato E, et al. Among authors: bonifati c. Clin Exp Dermatol. 2025 Aug 22;50(9):1786-1794. doi: 10.1093/ced/llaf172. Clin Exp Dermatol. 2025. PMID: 40238960
Cytokines in psoriasis.
Bonifati C, Ameglio F. Bonifati C, et al. Int J Dermatol. 1999 Apr;38(4):241-51. doi: 10.1046/j.1365-4362.1999.00622.x. Int J Dermatol. 1999. PMID: 10321938 Review. No abstract available.
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).
Orsini D, Caldarola G, Dattola A, Campione E, Bernardini N, Frascione P, De Simone C, Richetta AG, Galluzzo M, Skroza N, Assorgi C, Amore E, Falco GM, Gaeta Shumak R, Artosi F, Maretti G, Potenza C, Bianchi L, Pellacani G, Peris K, Bonifati C, Graceffa D. Orsini D, et al. Among authors: bonifati c. J Dermatolog Treat. 2024 Dec;35(1):2319304. doi: 10.1080/09546634.2024.2319304. Epub 2024 Feb 27. J Dermatolog Treat. 2024. PMID: 38413097 Free article.
Psoriasis and Emotional Dysregulation: A Multicenter Analysis of Psychodermatology Outcomes.
Samela T, Moretta G, Provini A, Pagnanelli G, Bonifati C, Graceffa D, Lora V, Orsini D, Zangrilli A, Giordano D, Dattola A, Richetta A, Bernardini N, Caldarola G, De Luca E, Masini C, Bavetta M, Tribuzi P, Panasiti V, Abeni D. Samela T, et al. Among authors: bonifati c. Dermatol Pract Concept. 2025 Apr 1;15(2):4644. doi: 10.5826/dpc.1502a4644. Dermatol Pract Concept. 2025. PMID: 40401857 Free PMC article.
Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms.
Dattola A, Bernardini N, Anedda J, Atzori L, Bonifati C, Bruni PL, Giordano D, Graceffa D, Molinelli E, Moretta G, Mugheddu C, Offidani A, Pagnanelli G, Pallotta S, Papini M, Persechino S, Richetta AG, Tolino E, Trovato F, Pellacani G, Potenza C. Dattola A, et al. Among authors: bonifati c. Drugs Context. 2025 Sep 8;14:2025-5-1. doi: 10.7573/dic.2025-5-1. eCollection 2025. Drugs Context. 2025. PMID: 40948988 Free PMC article.
119 results